ArticleEuropean radiology2019
Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Mediation and prognostic value of apparent diffusion coefficient in HCC patients receiving immune checkpoint inhibitors.Insights into imaging · 2025Article
- Prognostic factors of locally advanced cervical cancer after concurrent chemoradiotherapy: a retrospective study.BMC cancer · 2025Article
- Multi-model quantitative MRI of uterine cancers in precision medicine's era-a narrative review.Insights into imaging · 2025Article
- Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025Article
- The apparent diffusion coefficient as a biomarker in the diagnosis of cervical cancer and the assessment of therapeutic response to chemoradiation therapy.Frontiers in oncology · 2025Article
- Analysis of the efficacy and safety of camrelizumab combined with chemotherapy for cervical cancer treatment.Frontiers in oncology · 2025Article
- A feasibility study of reduced full-of-view synthetic high-b-value diffusion-weighted imaging in uterine tumors.Insights into imaging · 2023Article
- Development of a combined model incorporating clinical characteristics and magnetic resonance imaging features to enhance the predictive value of a prognostic model for locally advanced cervical cancer.Frontiers in oncology · 2023Article
- Article
- Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix.PeerJ · 2023Article
- MRI outcome evaluation in patients with IB2 and IIA2 squamous cervical cancer stages: preliminary results.Insights into imaging · 2022Article
- Intravoxel Incoherent Motion (IVIM) MR Quantification in Locally Advanced Cervical Cancer (LACC): Preliminary Study on Assessment of Tumor Aggressiveness and Response to Neoadjuvant Chemotherapy.Journal of personalized medicine · 2022Article
- Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.European radiology · 2022Article
- Quantitative analysis of superb microvascular imaging for monitoring tumor response to chemoradiotherapy in locally advanced cervical cancer.Frontiers in oncology · 2022Article
- Post treatment imaging in patients with local advanced cervical carcinoma.Frontiers in oncology · 2022Review
- Combination of Radiomics and Machine Learning with Diffusion-Weighted MR Imaging for Clinical Outcome Prognostication in Cervical Cancer.Tomography (Ann Arbor, Mich.) · 2021Article
- Diagnosis Value of Colposcope Combined with Serum Squamous Cell Carcinoma Antigen, Carbohydrate Antigen 125, and Carcinoembryonic Antigen for Moderate to Advanced Cervical Cancer Patients Treated with Modified Fuzheng Peiyuan Decoction.Evidence-based complementary and alternative medicine : eCAM · 2021Article
- Predicting factors for primary cervical cancer recurrence after definitive radiation therapy.BJR open · 2021Article
- Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer.Journal of computer assisted tomographyArticle
- Role of ADC values in assessing clinical response and identifying residual disease post-chemo radiation in uterine cervix cancer.The Indian journal of radiology & imagingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesTo investigate the prognostic value of diffusion-weighted imaging (DWI) in predicting clinical outcome in patients with cervical cancer after concurrent chemoradiotherapy (CCRT).
methodsWe enrolled 124 cervical cancer patients who received definitive CCRT and underwent 3 T-MRI before and 1 month after initiating treatment. The mean apparent diffusion coefficient (ADC) value was measured on the tumor and the changes in ADC percentage (ΔADC
resultsIn multivariate analysis, ΔADC
conclusionThe percentage change in tumor ADC may be a useful predictor of disease progression and survival in patients with cervical cancer treated with CCRT. KEY POINTS: • DWI is widely used as a potential marker of tumor viability. • Percentage change in tumor ADC (ΔADC
Indexed as
Identifiers
30980126What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.